
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (12): 1459-1464.DOI: 10.12114/j.issn.1007-9572.2024.0118
Special Issue: 老年问题最新文章合辑; 老年人群健康最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2024-04-25
Revised:2024-06-19
Published:2025-04-20
Online:2025-02-06
Contact:
GUO Shubin
通讯作者:
郭树彬
作者简介:作者贡献:
李秋敬负责研究设计、数据收集、统计分析、论文撰写;商娜进行数据收集与整理、论文修订;高倩、杨黎进行数据收集、统计分析指导;郭树彬负责论文审校、质量控制,对文章整体负责。所有作者确认了论文的最终稿。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0118
| 项目 | 生存组(n=250) | 死亡组(n=85) | 检验统计量值 | P值 |
|---|---|---|---|---|
| 年龄[M(P25,P75),岁] | 76(69,84) | 82(75,88) | 3.745 | <0.001 |
| 性别[例(%)] | 0.010a | 0.979 | ||
| 男 | 121(48.4) | 41(48.2) | ||
| 女 | 129(51.6) | 44(51.8) | ||
| BMI(kg/m2) | 23.4±3.6 | 22.0±3.8 | -3.179b | 0.002 |
| 基础疾病[例(%)] | ||||
| 高血压 | 123(49.2) | 52(61.2) | 3.647a | 0.056 |
| 冠状动脉粥样硬化性心脏病 | 76(30.4) | 25(29.4) | 0.029a | 0.864 |
| 2型糖尿病 | 94(37.6) | 29(34.1) | 0.331a | 0.565 |
| 恶性肿瘤 | 40(16.0) | 21(24.7) | 3.228a | 0.072 |
| 慢性肾脏病 | 33(13.2) | 17(20.0) | 2.310a | 0.129 |
| 慢性肺部疾病 | 21(8.4) | 8(9.4) | 0.082a | 0.774 |
| 慢性肝脏疾病 | 11(4.4) | 4(4.7) | 0.014a | 0.906 |
| 实验室检查指标[M(P25,P75)] | ||||
| 白细胞计数(×109/L) | 10.88(7.11,14.30) | 10.37(7.39,16.63) | 0.943 | 0.346 |
| 中性粒细胞计数(×109/L) | 8.76(5.06,12.81) | 9.19(6.25,14.77) | 1.169 | 0.243 |
| 血红蛋白(g/L) | 121(103,138) | 116(84,137) | -1.959 | 0.050 |
| 血小板计数(×109/L) | 189(137,240) | 181(119,257) | -0.561 | 0.575 |
| 白蛋白(g/L) | 37.3(33.3,41.5) | 33.5(29.5,39.2) | -4.283 | <0.001 |
| 肌酐(μmol/L) | 83.6(63.2,129.6) | 140.3(74.5,244.4) | 3.730 | <0.001 |
| D-二聚体(mg/L) | 2.11(1.21,3.82) | 2.11(1.60,6.52) | 1.757 | 0.079 |
| 降钙素原(ng/mL) | 0.81(0.16,2.22) | 0.81(0.36,7.23) | 2.123 | 0.034 |
| L3 SMI[M(P25,P75),cm2/m2] | 34.82(30.19,41.26) | 30.38(24.78,32.87) | -5.817 | <0.001 |
| NRS2002评分[M(P25,P75),分] | 3(2,4) | 4(4,6) | 6.526 | <0.001 |
| 脓毒性休克[例(%)] | 70(28.0) | 46(54.1) | 19.115a | <0.001 |
| SOFA评分[M(P25,P75),分] | 3(2,5) | 6(4,9) | 6.820 | <0.001 |
| APACHE Ⅱ评分[M(P25,P75),分] | 11(6,15) | 17(11,24) | 6.688 | <0.001 |
| 住院时间[M(P25,P75),d] | 10(6,14) | 8(3,18) | -1.053 | 0.293 |
Table 1 Comparison of clinical characteristics between survival and non-survival group among older patients with intra-abdominal sepsis
| 项目 | 生存组(n=250) | 死亡组(n=85) | 检验统计量值 | P值 |
|---|---|---|---|---|
| 年龄[M(P25,P75),岁] | 76(69,84) | 82(75,88) | 3.745 | <0.001 |
| 性别[例(%)] | 0.010a | 0.979 | ||
| 男 | 121(48.4) | 41(48.2) | ||
| 女 | 129(51.6) | 44(51.8) | ||
| BMI(kg/m2) | 23.4±3.6 | 22.0±3.8 | -3.179b | 0.002 |
| 基础疾病[例(%)] | ||||
| 高血压 | 123(49.2) | 52(61.2) | 3.647a | 0.056 |
| 冠状动脉粥样硬化性心脏病 | 76(30.4) | 25(29.4) | 0.029a | 0.864 |
| 2型糖尿病 | 94(37.6) | 29(34.1) | 0.331a | 0.565 |
| 恶性肿瘤 | 40(16.0) | 21(24.7) | 3.228a | 0.072 |
| 慢性肾脏病 | 33(13.2) | 17(20.0) | 2.310a | 0.129 |
| 慢性肺部疾病 | 21(8.4) | 8(9.4) | 0.082a | 0.774 |
| 慢性肝脏疾病 | 11(4.4) | 4(4.7) | 0.014a | 0.906 |
| 实验室检查指标[M(P25,P75)] | ||||
| 白细胞计数(×109/L) | 10.88(7.11,14.30) | 10.37(7.39,16.63) | 0.943 | 0.346 |
| 中性粒细胞计数(×109/L) | 8.76(5.06,12.81) | 9.19(6.25,14.77) | 1.169 | 0.243 |
| 血红蛋白(g/L) | 121(103,138) | 116(84,137) | -1.959 | 0.050 |
| 血小板计数(×109/L) | 189(137,240) | 181(119,257) | -0.561 | 0.575 |
| 白蛋白(g/L) | 37.3(33.3,41.5) | 33.5(29.5,39.2) | -4.283 | <0.001 |
| 肌酐(μmol/L) | 83.6(63.2,129.6) | 140.3(74.5,244.4) | 3.730 | <0.001 |
| D-二聚体(mg/L) | 2.11(1.21,3.82) | 2.11(1.60,6.52) | 1.757 | 0.079 |
| 降钙素原(ng/mL) | 0.81(0.16,2.22) | 0.81(0.36,7.23) | 2.123 | 0.034 |
| L3 SMI[M(P25,P75),cm2/m2] | 34.82(30.19,41.26) | 30.38(24.78,32.87) | -5.817 | <0.001 |
| NRS2002评分[M(P25,P75),分] | 3(2,4) | 4(4,6) | 6.526 | <0.001 |
| 脓毒性休克[例(%)] | 70(28.0) | 46(54.1) | 19.115a | <0.001 |
| SOFA评分[M(P25,P75),分] | 3(2,5) | 6(4,9) | 6.820 | <0.001 |
| APACHE Ⅱ评分[M(P25,P75),分] | 11(6,15) | 17(11,24) | 6.688 | <0.001 |
| 住院时间[M(P25,P75),d] | 10(6,14) | 8(3,18) | -1.053 | 0.293 |
| 变量 | β | SE | Wald χ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|---|
| L3 SMI | -0.079 | 0.021 | 13.569 | 0.924 | 0.886~0.964 | <0.001 |
| NRS2002评分 | 0.271 | 0.097 | 7.898 | 1.312 | 1.086~1.585 | 0.005 |
| SOFA评分 | 0.157 | 0.054 | 8.516 | 1.170 | 1.053~1.300 | 0.004 |
| APACHE Ⅱ评分 | 0.051 | 0.024 | 4.305 | 1.052 | 1.003~1.103 | 0.038 |
| 常数项 | -1.129 | 0.875 | 1.663 | 0.323 | 0.197 |
Table 2 Multivariable Logistic regression analysis of risk factors associated with in-hospital mortality among older patients with intra-abdominal sepsis
| 变量 | β | SE | Wald χ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|---|
| L3 SMI | -0.079 | 0.021 | 13.569 | 0.924 | 0.886~0.964 | <0.001 |
| NRS2002评分 | 0.271 | 0.097 | 7.898 | 1.312 | 1.086~1.585 | 0.005 |
| SOFA评分 | 0.157 | 0.054 | 8.516 | 1.170 | 1.053~1.300 | 0.004 |
| APACHE Ⅱ评分 | 0.051 | 0.024 | 4.305 | 1.052 | 1.003~1.103 | 0.038 |
| 常数项 | -1.129 | 0.875 | 1.663 | 0.323 | 0.197 |
Figure 2 The ROC curves of L3 SMI,SOFA score,APACHE Ⅱ score and combined variables on the risk of in-hospital mortality in older patients with intra-abdominal sepsis
| 变量 | AUC(95%CI) | 最佳截断值 | 约登指数 | 灵敏度 | 特异度 | P值 |
|---|---|---|---|---|---|---|
| L3 SMI | 0.711(0.650~0.772) | 33.30 cm2/m2 | 0.364 | 0.788 | 0.576 | <0.001 |
| SOFA评分 | 0.740(0.675~0.806) | 5.5分 | 0.455 | 0.647 | 0.808 | <0.001 |
| APACHE Ⅱ评分 | 0.742(0.684~0.801) | 12.5分 | 0.346 | 0.718 | 0.628 | <0.001 |
| L3 SMI联合SOFA评分 | 0.795(0.742~0.847) | 0.336 | 0.468 | 0.600 | 0.868 | <0.001 |
| L3 SMI联合APACHE Ⅱ评分 | 0.792(0.741~0.844) | 0.221 | 0.452 | 0.776 | 0.676 | <0.001 |
Table 3 The predictive value of L3 SMI,SOFA score,APACHEⅡ score and combined variables on the risk of in-hospital mortality in older patients with intra-abdominal sepsis
| 变量 | AUC(95%CI) | 最佳截断值 | 约登指数 | 灵敏度 | 特异度 | P值 |
|---|---|---|---|---|---|---|
| L3 SMI | 0.711(0.650~0.772) | 33.30 cm2/m2 | 0.364 | 0.788 | 0.576 | <0.001 |
| SOFA评分 | 0.740(0.675~0.806) | 5.5分 | 0.455 | 0.647 | 0.808 | <0.001 |
| APACHE Ⅱ评分 | 0.742(0.684~0.801) | 12.5分 | 0.346 | 0.718 | 0.628 | <0.001 |
| L3 SMI联合SOFA评分 | 0.795(0.742~0.847) | 0.336 | 0.468 | 0.600 | 0.868 | <0.001 |
| L3 SMI联合APACHE Ⅱ评分 | 0.792(0.741~0.844) | 0.221 | 0.452 | 0.776 | 0.676 | <0.001 |
| 指标 | 差异 | Z值 | P值 |
|---|---|---|---|
| SOFA评分比L3 SMI | 0.029 | 0.651 | 0.515 |
| L3 SMI联合SOFA评分比L3 SMI | 0.084 | 3.587 | <0.001 |
| L3 SMI联合SOFA评分比SOFA评分 | 0.054 | 2.114 | 0.035 |
| L3 SMI联合SOFA评分比APACHE Ⅱ评分 | 0.052 | 1.577 | 0.115 |
| L3 SMI联合SOFA评分比APACHE Ⅱ评分联合L3 SMI | 0.002 | 0.131 | 0.895 |
| APACHE Ⅱ评分比L3 SMI | 0.031 | 0.722 | 0.470 |
| APACHE Ⅱ评分比SOFA评分 | 0.002 | 0.058 | 0.954 |
| L3 SMI联合APACHE Ⅱ评分比L3 SMI | 0.081 | 3.634 | <0.001 |
| L3 SMI联合APACHE Ⅱ评分比APACHE Ⅱ评分 | 0.050 | 2.075 | 0.038 |
| L3 SMI联合APACHE Ⅱ评分比SOFA评分 | 0.052 | 1.442 | 0.149 |
Table 4 Comparison of the predictive value of L3 SMI,SOFA score,APACHEⅡ score and combined variables on the risk of in-hospital mortality in older patients with intra-abdominal sepsis
| 指标 | 差异 | Z值 | P值 |
|---|---|---|---|
| SOFA评分比L3 SMI | 0.029 | 0.651 | 0.515 |
| L3 SMI联合SOFA评分比L3 SMI | 0.084 | 3.587 | <0.001 |
| L3 SMI联合SOFA评分比SOFA评分 | 0.054 | 2.114 | 0.035 |
| L3 SMI联合SOFA评分比APACHE Ⅱ评分 | 0.052 | 1.577 | 0.115 |
| L3 SMI联合SOFA评分比APACHE Ⅱ评分联合L3 SMI | 0.002 | 0.131 | 0.895 |
| APACHE Ⅱ评分比L3 SMI | 0.031 | 0.722 | 0.470 |
| APACHE Ⅱ评分比SOFA评分 | 0.002 | 0.058 | 0.954 |
| L3 SMI联合APACHE Ⅱ评分比L3 SMI | 0.081 | 3.634 | <0.001 |
| L3 SMI联合APACHE Ⅱ评分比APACHE Ⅱ评分 | 0.050 | 2.075 | 0.038 |
| L3 SMI联合APACHE Ⅱ评分比SOFA评分 | 0.052 | 1.442 | 0.149 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
中华医学会外科学分会外科感染与重症医学学组,中国医师协会外科医师分会肠瘘外科医师专业委员会. 中国腹腔感染诊治指南(2019版)[J]. 中国实用外科杂志,2020,40(1):1-16. DOI:10.19538/j.cjps.issn1005-2208.2020.01.01.
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
中国急诊危重症患者肠内营养治疗专家共识组. 中国急诊危重症患者肠内营养治疗专家共识[J]. 中华急诊医学杂志,2022,31(3):281-290. DOI:10.3760/cma.j.issn.1671-0282.2022.03.004.
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
汪颖,王迪芬,付江泉,等. SOFA、qSOFA评分和传统指标对脓毒症预后的判断价值[J]. 中华危重病急救医学,2017,29(8):700-704. DOI:10.3760/cma.j.issn.2095-4352.2017.08.006.
|
| [21] |
|
| [22] |
李平娜,杨宏富,崔秋敏,等. 脓毒症患者细胞因子表达水平及其对预后的影响[J]. 中华危重病急救医学,2023,35(12):1250-1254. DOI:10.3760/cma.j.cn121430-20230818-00660.
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] | |
| [27] |
|
| [28] |
|
| [1] | ZENG Ling, XIE Leyun, YU Renhe, SONG Lin, ZENG Saizhen. Age-stratified Clinical Characteristics and Risk Factors for Lobar Pneumonia in Children with Mycoplasma Pneumoniae Pneumonia [J]. Chinese General Practice, 2026, 29(32): 4752-4758. |
| [2] | TANG Haoqing, LI Mingyue, LONG Ren, ZHU Yinbo, LIANG Weihuan, ZHU Ping, ZHAO Wei, ZHAO Yang, LIU Xiaoyun. Management Burden of Diabetic Mellitus Patients with Multimorbidity among Middle Aged and Older Adults: a Cross-sectional Survey in 6 Community Medical Institutes of China [J]. Chinese General Practice, 2026, 29(32): 4786-4797. |
| [3] | WANG Zhongkai, WU Changyong, LI Menghan, LUO Yihua, ZHANG Bingqing, PENG Yunzhu. Association between Remnant Cholesterol Inflammatory Index and Risk of Cardiometabolic Multimorbidity in Middle-aged and Older Adults [J]. Chinese General Practice, 2026, 29(31): 4573-4581. |
| [4] | LI Bin, GE Mengfei, HAN Jing, XIAO Yu, ZHONG Yu. The Influencing Factors of Physical and Mental Health of the Elderly at Home in the Community and the Empowerment Strategies of Medical Social Workers [J]. Chinese General Practice, 2026, 29(31): 4627-4634. |
| [5] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [6] | TANG Bo, YANG Rui, ZHAO Qian, LIU Hong, LIU Lidi, ZHANG Ying, JIANG Lihua, WANG Xiaogang, YANG Rong, LIAO Xiaoyang. Interpretation of the 2024 U.S. Preventive Services Task Force Recommendation Statement on Fall Prevention in Community-dwelling Older Adults [J]. Chinese General Practice, 2026, 29(30): 4360-4365. |
| [7] | ZHANG Shuaishuai, CHEN Yue, QIU Jiaojiao, ZHU Ping, WANG Shuxia. Association between Remnant Cholesterol Inflammatory Index and Biological Age Acceleration in Middle-aged and Older Chinese Adults: a Nationwide Cohort Study [J]. Chinese General Practice, 2026, 29(30): 4397-4405. |
| [8] | SUN Xiuqin, FENG Zhenlong, WEI Lanxuan, ZENG Yuxin, LIU Jinbo, MA Lin, AN Zhantian, WANG Hongyu. Analysis of the Current Status of Metabolic Syndrome among Middle-aged and Elderly People in Shijingshan District, Beijing, and Its Behavioral and Lifestyle Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4424-4430. |
| [9] | HE Qizhen, ZHONG Qingling, XU Jin, YU Yi, ZHAO Yuefei. Perceptions and Experiences of Zero-time Exercise among Community-dwelling Older Adults: a Qualitative Study [J]. Chinese General Practice, 2026, 29(30): 4480-4488. |
| [10] | HUANG Jiating, LIU Lingna, NING Yanhua, SHI Jing, LI Xinjin, YANG Cailing, YAO Jing. Consistency between Expressed and Perceived Needs for Family Doctor Contracted Services among Rural Older Adults: a Survey of 456 Residents in Ningxia [J]. Chinese General Practice, 2026, 29(29): 4217-4225. |
| [11] | CHEN Yujing, WANG Yan, LI Guang, DONG Benchao, YANG Peichuan, MA Jianxiong. Digital Technologies in the Management of Sarcopenia among Older Adults in Asia: a Scoping Review [J]. Chinese General Practice, 2026, 29(29): 4200-4210. |
| [12] | CHUN Liu, LEI Siyuan, FENG Zhenzhen, ZHAO Hulei, LI Jiansheng. Determination of Primary and Minor Symptoms of Common Syndromes in Sepsis Based on Clinical Investigation Combined with Expert Questionnaires [J]. Chinese General Practice, 2026, 29(29): 4345-4352. |
| [13] | ZHANG Tianyu, CHEN Fei, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia. Significance of Elevated Levels of Leukocyte Immunoglobulin-like Receptor B1, CD36, and Lymphatic Enhancer Factor 1 in Patients with Myeloma [J]. Chinese General Practice, 2026, 29(29): 4272-4280. |
| [14] | LI Jiao, ZHOU Jianjie, PENG Lang, MEI Yingbing, TAN Zihu. Development and Validation of a Risk Prediction Model for Poor Prognosis in Alzheimer's Disease Patients with Community-acquired Pneumonia [J]. Chinese General Practice, 2026, 29(29): 4248-4257. |
| [15] | YU Xinyan, ZHANG Fang, GU Zhile, WANG Yanfang, SU Peng, ZHANG Haicheng. Correlation between Fasting Plasma Glucose, Body Mass Index, and Waist Circumference among Community-dwelling Elderly Individuals [J]. Chinese General Practice, 2026, 29(28): 4132-4140. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||